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Response to Letter to the Editor: ‘Epidemiology should not be forgotten
in osteoarthritis imaging’We appreciate the opportunity to respond to the thoughtful
letter by Cicuttini et al. It raises a number of points that were not
clear after completing the review.
Firstly, we recommended “involvement of an expert musculoskel-
etal radiologist in theearlyphaseof studydesignand in thepeer review
process should be strongly encouraged for papers dealing with osteo-
arthritis (OA) imaging derived data”. We stand by this suggestion.
In contrast to what was suggested in the letter at no point in the
review did we recommend that the peer review process be
“restricted to this specialty group”. We wholeheartedly agree that
the review process involve and engage multiple disciplines
including people with expertise in measurement methods as well
as persons with expertise in imaging methods. We believe Cicuttini
et al. are acquitted with our work in OA and hence realize our
commitment to the multidisciplinary approach.
At no point was it suggested that epidemiology be forgotten as
suggested in the title of the letter. Our review article focuses on
a review of imaging of OA for the year 2010. It would have been
inappropriate to include detailed discussion of epidemiology,
genetics, pathogenesis or therapy of OA in this particular review
article as they were topics from accompanying reviews in this issue
stemming from presentations at the annual scientiﬁc meeting.
We also strongly agree with Cicuttini et al. that pursuit of
rigorous scientiﬁc methods is critical in reporting in the medical
literature. We are fortunate to work in a ﬁeld with multiple disci-
plines involved. Engaging appropriate disciplines (e.g., musculo-
skeletal radiologists, biomechanists) in the study design and peer
review process should not be seen as threatening but rather enrich-
ing the process of rigorous peer review.
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